CA
NZ
UK
AU
IND
US
…
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Income before tax | -0.09M | -0.76M | 1.69M | 1.19M | -1.88M |
| Net income | -0.10M | -0.78M | 1.31M | 1.01M | -2.09M |
| Selling general administrative | 3.55M | 3.80M | 3.95M | 3.71M | 9.21M |
| Gross profit | 2.91M | 2.52M | 5.07M | 4.88M | 5.36M |
| Reconciled depreciation | 0.23M | 0.18M | 0.19M | 0.05M | 0.07M |
| Ebit | - | - | - | 1.17M | -3.85M |
| Ebitda | - | - | - | 1.23M | -3.78M |
| Operating income | -0.64M | -1.29M | 1.12M | 1.17M | -3.85M |
| Interest expense | - | - | - | - | 0.00M |
| Tax provision | 0.01M | 0.02M | 0.38M | 0.18M | 0.21M |
| Income tax expense | - | - | - | 0.18M | 0.21M |
| Total revenue | 9.00M | 9.51M | 16.98M | 19.40M | 20.12M |
| Total operating expenses | 9.64M | 10.80M | 15.86M | 18.22M | 23.97M |
| Cost of revenue | 6.09M | 6.99M | 11.91M | 14.52M | 14.76M |
| Total other income expense net | 0.54M | 0.53M | 0.57M | 0.01M | 1.98M |
| Net income from continuing ops | -0.10M | -0.78M | 1.31M | 1.01M | -2.09M |
| Net income applicable to common shares | - | - | - | 1.01M | -2.09M |
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Total assets | 13.65M | 16.29M | 19.90M | 20.65M | 23.92M |
| Other current assets | 0.17M | 0.44M | 0.48M | - | - |
| Total liab | 1.74M | 2.58M | 3.78M | 4.09M | 5.01M |
| Total stockholder equity | 11.91M | 13.72M | 16.13M | 16.56M | 18.91M |
| Other current liab | - | - | - | 0.34M | 0.45M |
| Common stock | - | - | - | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | 10.53M | 12.35M | 14.85M | 15.27M | 17.71M |
| Other liab | - | - | - | 1.64M | 1.85M |
| Other assets | - | - | - | 0.13M | 0.35M |
| Cash | 3.38M | 6.77M | 10.45M | 14.46M | 17.47M |
| Total current liabilities | 1.74M | 1.89M | 2.15M | 2.11M | 2.67M |
| Other stockholder equity | - | - | - | 0.24M | 0.14M |
| Property plant equipment | - | - | - | 0.58M | 0.75M |
| Total current assets | 13.39M | 15.70M | 19.40M | 19.94M | 22.82M |
| Net tangible assets | - | - | - | 16.56M | 18.91M |
| Short term investments | 7.48M | 5.98M | 4.53M | - | - |
| Net receivables | 2.36M | 2.51M | 3.94M | 4.98M | 4.61M |
| Accounts payable | 0.99M | 1.13M | 1.47M | 1.63M | 2.09M |
| Non currrent assets other | 0.12M | 0.23M | 0.11M | 0.13M | 0.35M |
| Non current assets total | 0.27M | 0.59M | 0.50M | 0.71M | 1.10M |
| Capital lease obligations | 0.03M | 0.19M | 0.35M | 0.49M | 0.62M |
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Investments | -1.46M | -1.20M | -4.22M | -0.02M | 1.30M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | - | - | - | -0.02M | 1.30M |
| Total cash from financing activities | -1.75M | -1.73M | -1.76M | -3.53M | -1.75M |
| Change to operating activities | - | - | - | -0.07M | -0.38M |
| Net income | -0.10M | -0.78M | 1.31M | 1.01M | -2.09M |
| Change in cash | -3.39M | -3.68M | -4.02M | -3.01M | 0.33M |
| Begin period cash flow | 6.77M | 10.45M | 14.46M | 17.47M | 17.14M |
| End period cash flow | 3.38M | 6.77M | 10.45M | 14.46M | 17.47M |
| Total cash from operating activities | -0.21M | -0.57M | 1.89M | 0.59M | 0.80M |
| Depreciation | 0.23M | 0.18M | 0.19M | 0.05M | 0.07M |
| Other cashflows from investing activities | - | - | - | - | 1.25M |
| Dividends paid | 1.72M | 1.72M | 1.72M | 3.45M | 1.73M |
| Change to account receivables | 0.20M | 1.46M | 1.09M | -0.46M | -0.13M |
| Sale purchase of stock | -0.03M | -0.01M | -0.03M | -0.08M | -0.03M |
| Change to netincome | - | - | - | 0.07M | 3.34M |
| Capital expenditures | 0.01M | 0.16M | 0.01M | 0.02M | 0.01M |
| Change in working capital | -0.34M | 0.23M | 0.66M | -0.54M | -0.52M |
| Stock based compensation | 0.04M | 0.05M | 0.05M | 0.07M | 0.06M |
| Other non cash items | -0.04M | -0.25M | -0.32M | - | - |
| Free cash flow | -0.22M | -0.73M | 1.88M | 0.57M | 0.79M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PBSV Pharma-Bio Serv Inc |
-0.05 10.78% |
0.40 | - | 4.91 | 1.36 | 1.18 | 0.17 | 4.75 |
| VEEV Veeva Systems Inc Class A |
-4.72 1.48% |
313.46 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
129.00 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
4.99 7.43% |
72.15 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.07 1.16% |
5.95 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
| Name | Title | Year Born |
|---|---|---|
| Mr. Victor Sanchez | CEO, Pres & Pres of European Operations | 1971 |
| Ms. Elizabeth Plaza | Founder & Sr. Strategic Consultant | 1964 |
| Mr. Pedro J. Lasanta | CFO, VP of Fin. & Admin. and Sec. | 1960 |
| Ms. Miriam Marrero M.B.A. | HR Mang. | NA |
| Mr. Victor Sanchez | CEO, President & President of European Operations | 1971 |
| Mr. Pedro J. Lasanta | CFO, VP of Finance & Administration and Secretary | 1960 |
| Ms. Miriam Marrero M.B.A. | Human Resources Manager | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+1.59%
Communication Services
+0.05%
Consumer Cyclical
+0.14%
Consumer Defensive
-0.43%
Energy
-0.03%
Financial Services
+0.19%
Financials
-0.35%
Healthcare
+1.05%
Industrials
+0.67%
Real Estate
-0.25%
Technology
+1.31%
Utilities
+0.32%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...